Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Vaccine (Split Virion), Inactivated in Children
CTR20211439Phase 2Completed
- Sponsor
- Tianyuan Bio-Pharmaceutical
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of quadrivalent influenza vaccine in influenza, sponsored by Tianyuan Bio-Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20211439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211439.